What is the address of Dr. O. Yazar, Vascular Care?

The registered office of Dr. O. Yazar, Vascular Care is located at Houterstraat 113, 3620 Lanaken.

Is Dr. O. Yazar, Vascular Care still active?

Yes. According to the CBE (30 September 2026) Dr. O. Yazar, Vascular Care is active, legal situation “Normale toestand”, started on 9 November 2016.

Is Dr. O. Yazar, Vascular Care registered on Peppol?

Yes, Dr. O. Yazar, Vascular Care is registered on the Peppol network with ID 0208:0665854025.

What is the enterprise number of Dr. O. Yazar, Vascular Care?

The enterprise number of Dr. O. Yazar, Vascular Care is BE0665854025.

When was Dr. O. Yazar, Vascular Care founded?

Dr. O. Yazar, Vascular Care was founded on 9 November 2016.

Who are the directors of Dr. O. Yazar, Vascular Care?

According to the 2025 annual accounts, the directors of Dr. O. Yazar, Vascular Care are: Ozan Yazar.

Is Dr. O. Yazar, Vascular Care a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 November 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. O. Yazar, Vascular Care make in 2025?

Dr. O. Yazar, Vascular Care posted a profit after taxes of € 143,480 in financial year 2025.

What is the revenue of Dr. O. Yazar, Vascular Care?

As a small company, Dr. O. Yazar, Vascular Care is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 205,698.

Dr. O. Yazar, Vascular Care (Private Limited) - Lanaken

Dossier Dr. O. Yazar, Vascular Care, printed on 30 September 2026 from databakkes.be/en/0665854025/dr-o-yazar-vascular-care. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. O. Yazar, Vascular Care from Lanaken, company number BE0665854025, closed financial year 2025 with a result of € 143,480 after tax. For that financial year Dr. O. Yazar, Vascular Care recorded a gross margin of € 205,698 and equity of € 22,965. Compared with financial year 2024, the result moved from € 148,485 to € 143,480. The company is profitable. The buffer shrank hard: equity is 54 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.

What it is worth Shrank hard

€ 22,965

▼ 54% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 143,480

▼ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 22,520

▲ € 18,005 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 170,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 2,262

▼ 28% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,864

▲ 55% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,733

▼ 60% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 131,493 Gross margin 2022: € 131,493 First fiscal year in the series	€ 168,778 Gross margin 2023: € 168,778 ▲ 28% vs 2022 (€ 131,493) Favourable step	€ 210,419 Gross margin 2024: € 210,419 ▲ 25% vs 2023 (€ 168,778) Favourable step	€ 205,698 Gross margin 2025: € 205,698 ▼ 2% vs 2024 (€ 210,419) Unfavourable step	▼ 2%
Profit after taxes	€ 88,137 Profit after taxes 2022: € 88,137 First fiscal year in the series	€ 113,190 Profit after taxes 2023: € 113,190 ▲ 28% vs 2022 (€ 88,137) Favourable step	€ 148,485 Profit after taxes 2024: € 148,485 ▲ 31% vs 2023 (€ 113,190) Favourable step	€ 143,480 Profit after taxes 2025: € 143,480 ▼ 3% vs 2024 (€ 148,485) Unfavourable step	▼ 3%
Equity	€ 461,575 Equity 2022: € 461,575 First fiscal year in the series	€ 574,766 Equity 2023: € 574,766 ▲ 25% vs 2022 (€ 461,575) Favourable step	€ 49,485 Equity 2024: € 49,485 ▼ 91% vs 2023 (€ 574,766) Unfavourable step	€ 22,965 Equity 2025: € 22,965 ▼ 54% vs 2024 (€ 49,485) Unfavourable step	▼ 54%
Total debts	€ 99,669 Total debts 2022: € 99,669 First fiscal year in the series	€ 38,098 Total debts 2023: € 38,098 ▼ 62% vs 2022 (€ 99,669) Favourable step	€ 202,951 Total debts 2024: € 202,951 ▲ € 164,853 vs 2023 (€ 38,098) Unfavourable step	€ 201,596 Total debts 2025: € 201,596 ▼ 1% vs 2024 (€ 202,951) Favourable step	▼ 1%
Cash	€ 314,659 Cash 2022: € 314,659 First fiscal year in the series	€ 145,215 Cash 2023: € 145,215 ▼ 54% vs 2022 (€ 314,659) Unfavourable step	€ 4,515 Cash 2024: € 4,515 ▼ 97% vs 2023 (€ 145,215) Unfavourable step	€ 22,520 Cash 2025: € 22,520 ▲ € 18,005 vs 2024 (€ 4,515) Favourable step	▲ € 18,005
Retained profit	€ 442,975 Retained profit 2022: € 442,975 First fiscal year in the series	€ 556,166 Retained profit 2023: € 556,166 ▲ 26% vs 2022 (€ 442,975) Favourable step	€ 48,485 Retained profit 2024: € 48,485 ▼ 91% vs 2023 (€ 556,166) Unfavourable step	€ 21,965 Retained profit 2025: € 21,965 ▼ 55% vs 2024 (€ 48,485) Unfavourable step	▼ 55%
Dividend	€ 7,500 Dividend 2022: € 7,500 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 7,500) Unchanged	€ 656,166 Dividend 2024: € 656,166 Unchanged (€ 0) Unchanged	€ 170,000 Dividend 2025: € 170,000 ▼ 74% vs 2024 (€ 656,166) Unchanged	▼ 74%
Balance sheet total	€ 561,244 Balance sheet total 2022: € 561,244 First fiscal year in the series	€ 612,863 Balance sheet total 2023: € 612,863 ▲ 9% vs 2022 (€ 561,244) Unchanged	€ 252,436 Balance sheet total 2024: € 252,436 ▼ 59% vs 2023 (€ 612,863) Unchanged	€ 224,561 Balance sheet total 2025: € 224,561 ▼ 11% vs 2024 (€ 252,436) Unchanged	▼ 11%

Key figures of Dr. O. Yazar, Vascular Care, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. O. Yazar, Vascular Care?

What happened at Dr. O. Yazar, Vascular Care in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 23, 2026 New annual accounts for financial year 2025: profit of € 143,480 (▼ 3% vs 2024). Source: NBB ↗
2023 Ozan Yazar became a director. NBB
Nov 9, 2016 New establishment in Lanaken. KBO
Nov 9, 2016 Start of the company according to the CBE. KBO

In short

From € 88,137 profit in 2022 to € 143,480 profit in 2025.

Paid € 117,044 in corporate taxes since 2022.

Best year ever: 2024, with € 148,485 profit.

Paid out € 833,666 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. O. Yazar, Vascular Care? We notify you, reason included.

Follow Dr. O. Yazar, Vascular Care

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ozan Yazar

Dr. O. Yazar, Vascular Care

Behind Dr. O. Yazar, Vascular Care is Ozan Yazar.

See the full network in the app

Directors

According to the 2025 annual accounts

Ozan Yazar

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Houterstraat 113

3620 Lanaken

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0665.854.025
VAT number: BE 0665.854.025
Registered office: Houterstraat 113, 3620 Lanaken
Names & denominations: Dr. O. Yazar, Vascular Care
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 November 2016
Peppol: Active · Active since 1 Jan 2001

View on CBE Public ↗ Annual accounts (NBB) ↗